About the role

Cellares is building a next-generation Integrated Digital Manufacturing Operations (IDMO) platform to enable scalable, GMP-compliant cell therapy manufacturing. As part of this transformation, we are establishing a modern enterprise data foundation powered by Databricks to unify data across engineering, manufacturing, quality, supply chain, finance and commercial systems.

We are seeking a Principal Enterprise Data Architect, a highly hands-on individual contributor who will design, build, and operationalize our enterprise data platform from the ground up.

This is a multidisciplinary role and this individual will play a critical role in enabling real-time decision-making, data governance, and AI readiness across the enterprise. This role is a startup-style builder (90% hands-on) and will evolve into a foundational leader for scaling data capabilities, including alignment with our Global Capability Center (GCC).

Candidates should enjoy working in a fast-paced, mission-driven environment, and be prepared to tackle a broad selection of challenges as the company grows.

Skills & Tags

go ai data design

Aplyr's read

Cellares is revolutionizing cell therapy manufacturing through automation, attracting professionals keen on innovation in biotechnology and operational efficiency.
Synthesized from recent postings & public sources

What's promising

•Cellares focuses on automating cell therapy, addressing a critical need for efficiency in biotechnology.
•The company offers diverse roles, indicating growth and a dynamic work environment.
•Cellares is committed to improving accessibility in cell therapy, a rapidly growing field.

What to watch

•The niche focus on cell therapy may limit broader career opportunities.
•As a biotech company, Cellares faces regulatory challenges that can impact timelines.
•Limited public information about financial stability and long-term viability.

Why Cellares

•Cellares' automation focus sets it apart in the cell therapy manufacturing sector.
•The company integrates advanced technology roles, like Enterprise AI, into biotech.
•Cellares' commitment to accessibility in cell therapy is a distinctive mission.

Aplyr’s read is generated by AI from public sources. Was it useful?